,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1349820,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,8639,AOC3,https://ctdbase.org/detail.go?type=gene&acc=8639,,,8639.0,AOC3,10090,Mus musculus (house mouse),Titanium dioxide results in decreased expression of AOC3 mRNA,,,PMID:23557971,https://www.ncbi.nlm.nih.gov/pubmed/23557971,23557971,,
1,1349821,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,71724,AOX3,https://ctdbase.org/detail.go?type=gene&acc=71724,,,71724.0,Aox3,10090,Mus musculus (house mouse),Titanium dioxide results in increased expression of AOX3 mrna|resveratrol inhibits the reaction [titanium dioxide results in increased expression of AOX3 mrna],,,PMID:31298478,https://www.ncbi.nlm.nih.gov/pubmed/31298478,31298478,,
2,1349822,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,71724,AOX3,https://ctdbase.org/detail.go?type=gene&acc=71724,,,71724.0,Aox3,10090,Mus musculus (house mouse),Titanium dioxide results in decreased expression of AOX3 mRNA,,,PMID:27760801,https://www.ncbi.nlm.nih.gov/pubmed/27760801,27760801,,
3,1349823,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,164,AP1G1,https://ctdbase.org/detail.go?type=gene&acc=164,,,164.0,AP1G1,10090,Mus musculus (house mouse),Titanium dioxide results in increased expression of AP1G1 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
4,1349961,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,68318,APH1C,https://ctdbase.org/detail.go?type=gene&acc=68318,,,68318.0,Aph1c,10090,Mus musculus (house mouse),Titanium dioxide results in decreased expression of APH1C mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
5,1349962,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,8862,APLN,https://ctdbase.org/detail.go?type=gene&acc=8862,,,8862.0,APLN,10090,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in decreased expression of APLN mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
6,1349963,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,8074,FGF23,https://ctdbase.org/detail.go?type=gene&acc=8074,,,8074.0,FGF23,10090,Mus musculus (house mouse),[titanium dioxide co-treated with azoxymethane co-treated with dextran sulfate] results in increased expression of FGF23 mRNA,,,PMID:29950665,https://www.ncbi.nlm.nih.gov/pubmed/29950665,29950665,,
7,1349964,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,8074,FGF23,https://ctdbase.org/detail.go?type=gene&acc=8074,,,8074.0,FGF23,10090,Mus musculus (house mouse),Titanium dioxide results in increased expression of FGF23 mRNA,,,PMID:29264374,https://www.ncbi.nlm.nih.gov/pubmed/29264374,29264374,,
8,1349965,26042,Comparative Toxicogenomics Database (CTD),Titanium Dioxide,C009495,titanium dioxide,https://ctdbase.org/detail.go?type=chem&acc=C009495,2252,FGF7,https://ctdbase.org/detail.go?type=gene&acc=2252,,,2252.0,FGF7,9606,Homo sapiens (human),Titanium dioxide results in decreased expression of FGF7 mRNA,,,PMID:34973136,https://www.ncbi.nlm.nih.gov/pubmed/34973136,34973136,,
9,1349276,40478,Toxin and Toxin Target Database (T3DB),"2,2',3,3',4,4',6-Heptachlorobiphenyl",T3D0560,"2,2',3,3',4,4',6-Heptachlorobiphenyl",http://www.t3db.ca/toxins/T3D0560,BE0000951,Estrogen sulfotransferase,http://www.t3db.ca/biodb/bio_entities/BE0000951,P49888,Sulfotransferase 1E1,6783.0,SULT1E1,9606,Homo sapiens (human),"Pcbs can cause endocrine disurption by binding to estrogen sulfotransferase, which can stimulate the growth of certain cancer cells and produce other estrogenic effects, such as reproductive dysfunction. (A3, A66)",,,PMID:11386736|PMID:10803601,https://www.ncbi.nlm.nih.gov/pubmed/11386736|https://www.ncbi.nlm.nih.gov/pubmed/10803601,11386736|10803601,,
10,1349277,40478,Toxin and Toxin Target Database (T3DB),"2,2',3,3',4,4',6-Heptachlorobiphenyl",T3D0560,"2,2',3,3',4,4',6-Heptachlorobiphenyl",http://www.t3db.ca/toxins/T3D0560,BE0002151,Aromatic-L-amino-acid decarboxylase,http://www.t3db.ca/biodb/bio_entities/BE0002151,P20711,Aromatic-L-amino-acid decarboxylase,1644.0,DDC,9606,Homo sapiens (human),PCB inhibition of aromatic-L-amino-acid decarboxylase is believed to cause decreased dopamine synthesis. (L4),,,,,,,
11,1349278,40478,Toxin and Toxin Target Database (T3DB),"2,2',3,3',4,4',6-Heptachlorobiphenyl",T3D0560,"2,2',3,3',4,4',6-Heptachlorobiphenyl",http://www.t3db.ca/toxins/T3D0560,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606,Homo sapiens (human),"Dioxin-like pcbs bind to the aryl hydrocarbon receptor, which disrupts cell function by altering the transcription of genes, mainly be inducing the expression of hepatic phase I and phase II enzymes, especially of the cytochrome P450 family. (A4)",,,PMID:2992927,https://www.ncbi.nlm.nih.gov/pubmed/2992927,2992927,,
12,1349279,40478,Toxin and Toxin Target Database (T3DB),"2,2',3,3',4,4',6-Heptachlorobiphenyl",T3D0560,"2,2',3,3',4,4',6-Heptachlorobiphenyl",http://www.t3db.ca/toxins/T3D0560,BE0000614,Tyrosine 3-monooxygenase,http://www.t3db.ca/biodb/bio_entities/BE0000614,P07101,Tyrosine 3-monooxygenase,7054.0,TH,9606,Homo sapiens (human),PCB inhibition of tyrosine 3-monooxygenase is believed to cause decreased dopamine synthesis. (L4),,,,,,,
13,1349280,40478,Toxin and Toxin Target Database (T3DB),"2,2',3,3',4,4',6-Heptachlorobiphenyl",T3D0560,"2,2',3,3',4,4',6-Heptachlorobiphenyl",http://www.t3db.ca/toxins/T3D0560,BE0004289,Uteroglobin,http://www.t3db.ca/biodb/bio_entities/BE0004289,P11684,Uteroglobin,7356.0,SCGB1A1,9606,Homo sapiens (human),Pcbs will bioaccumulate by binding to receptor proteins such as uteroglobin. (A30),,,PMID:11205532,https://www.ncbi.nlm.nih.gov/pubmed/11205532,11205532,,
14,1349815,40483,Toxin and Toxin Target Database (T3DB),"2,2',3,4,4',5,5',6-Octachlorobiphenyl",T3D0592,"2,2',3,4,4',5,5',6-Octachlorobiphenyl",http://www.t3db.ca/toxins/T3D0592,BE0000614,Tyrosine 3-monooxygenase,http://www.t3db.ca/biodb/bio_entities/BE0000614,P07101,Tyrosine 3-monooxygenase,7054.0,TH,9606,Homo sapiens (human),PCB inhibition of tyrosine 3-monooxygenase is believed to cause decreased dopamine synthesis. (L4),,,,,,,
15,1349816,40483,Toxin and Toxin Target Database (T3DB),"2,2',3,4,4',5,5',6-Octachlorobiphenyl",T3D0592,"2,2',3,4,4',5,5',6-Octachlorobiphenyl",http://www.t3db.ca/toxins/T3D0592,BE0004289,Uteroglobin,http://www.t3db.ca/biodb/bio_entities/BE0004289,P11684,Uteroglobin,7356.0,SCGB1A1,9606,Homo sapiens (human),Pcbs will bioaccumulate by binding to receptor proteins such as uteroglobin. (A30),,,PMID:11205532,https://www.ncbi.nlm.nih.gov/pubmed/11205532,11205532,,
16,1349817,40484,Toxin and Toxin Target Database (T3DB),"2,2',3,3',4,5,5',6,6'-Nonachlorobiphenyl",T3D0597,"2,2',3,3',4,5,5',6,6'-Nonachlorobiphenyl",http://www.t3db.ca/toxins/T3D0597,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
17,1349818,40484,Toxin and Toxin Target Database (T3DB),"2,2',3,3',4,5,5',6,6'-Nonachlorobiphenyl",T3D0597,"2,2',3,3',4,5,5',6,6'-Nonachlorobiphenyl",http://www.t3db.ca/toxins/T3D0597,BE0000792,Estrogen receptor beta,http://www.t3db.ca/biodb/bio_entities/BE0000792,Q92731,Estrogen receptor beta,2100.0,ESR2,9606,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
18,1349819,40484,Toxin and Toxin Target Database (T3DB),"2,2',3,3',4,5,5',6,6'-Nonachlorobiphenyl",T3D0597,"2,2',3,3',4,5,5',6,6'-Nonachlorobiphenyl",http://www.t3db.ca/toxins/T3D0597,BE0000951,Estrogen sulfotransferase,http://www.t3db.ca/biodb/bio_entities/BE0000951,P49888,Sulfotransferase 1E1,6783.0,SULT1E1,9606,Homo sapiens (human),"Pcbs can cause endocrine disurption by binding to estrogen sulfotransferase, which can stimulate the growth of certain cancer cells and produce other estrogenic effects, such as reproductive dysfunction. (A3, A66)",,,PMID:11386736|PMID:10803601,https://www.ncbi.nlm.nih.gov/pubmed/11386736|https://www.ncbi.nlm.nih.gov/pubmed/10803601,11386736|10803601,,
19,1348979,65324,Drug Gene Interaction database (DGIdb),Dobutamine Hydrochloride,,DOBUTAMINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203121,,ADRB1,https://www.dgidb.org/genes/hgnc:285,,,153.0,ADRB1,9606,Homo sapiens (human),Agonist,,,,,,,
20,1348980,65326,Drug Gene Interaction database (DGIdb),Ephedrine Hydrochloride,,EPHEDRINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:91165,,ADRA2A,https://www.dgidb.org/genes/hgnc:281,,,150.0,ADRA2A,9606,Homo sapiens (human),Agonist,,,,,,,
21,1348975,65332,ChEMBL,Pipecuronium Bromide,CHEMBL1200722,PIPECURONIUM BROMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200722/,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2362997/,P07510,Acetylcholine receptor subunit gamma,1146.0,CHRNG,9606,Homo sapiens (human),Muscle-type nicotinic acetylcholine receptor antagonist,,,PMID:1748153|PMID:9227834|PMID:12426786,https://www.ncbi.nlm.nih.gov/pubmed/1748153|https://www.ncbi.nlm.nih.gov/pubmed/9227834|https://www.ncbi.nlm.nih.gov/pubmed/12426786,1748153|9227834|12426786,,
22,1348976,65332,ChEMBL,Pipecuronium Bromide,CHEMBL1200722,PIPECURONIUM BROMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200722/,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2362997/,P11230,Acetylcholine receptor subunit beta,1140.0,CHRNB1,9606,Homo sapiens (human),Muscle-type nicotinic acetylcholine receptor antagonist,,,PMID:1748153|PMID:9227834|PMID:12426786,https://www.ncbi.nlm.nih.gov/pubmed/1748153|https://www.ncbi.nlm.nih.gov/pubmed/9227834|https://www.ncbi.nlm.nih.gov/pubmed/12426786,1748153|9227834|12426786,,
23,1348977,65332,ChEMBL,Pipecuronium Bromide,CHEMBL1200722,PIPECURONIUM BROMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200722/,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2362997/,Q04844,Acetylcholine receptor subunit epsilon,1145.0,CHRNE,9606,Homo sapiens (human),Muscle-type nicotinic acetylcholine receptor antagonist,,,PMID:1748153|PMID:9227834|PMID:12426786,https://www.ncbi.nlm.nih.gov/pubmed/1748153|https://www.ncbi.nlm.nih.gov/pubmed/9227834|https://www.ncbi.nlm.nih.gov/pubmed/12426786,1748153|9227834|12426786,,
24,1348978,65332,ChEMBL,Pipecuronium Bromide,CHEMBL1200722,PIPECURONIUM BROMIDE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200722/,CHEMBL2362997,Muscle-type nicotinic acetylcholine receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2362997/,Q07001,Acetylcholine receptor subunit delta,1144.0,CHRND,9606,Homo sapiens (human),Muscle-type nicotinic acetylcholine receptor antagonist,,,PMID:1748153|PMID:9227834|PMID:12426786,https://www.ncbi.nlm.nih.gov/pubmed/1748153|https://www.ncbi.nlm.nih.gov/pubmed/9227834|https://www.ncbi.nlm.nih.gov/pubmed/12426786,1748153|9227834|12426786,,
25,1348981,65357,Comparative Toxicogenomics Database (CTD),Peroxynitric acid,C039642,peroxynitric acid,https://ctdbase.org/detail.go?type=chem&acc=C039642,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606,Homo sapiens (human),Peroxynitric acid results in increased activity of PARP1 protein,,,PMID:17430113,https://www.ncbi.nlm.nih.gov/pubmed/17430113,17430113,,
26,1349399,65359,Comparative Toxicogenomics Database (CTD),Oxiglutatione,D019803,Glutathione Disulfide,https://ctdbase.org/detail.go?type=chem&acc=D019803,6517,SLC2A4,https://ctdbase.org/detail.go?type=gene&acc=6517,,,6517.0,SLC2A4,10090,Mus musculus (house mouse),Manganese(iii)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [SLC2A4 gene mutant form results in increased abundance of glutathione disulfide]|slc2a4 gene mutant form results in increased abundance of glutathione disulfide,,,PMID:22221582,https://www.ncbi.nlm.nih.gov/pubmed/22221582,22221582,,
27,1349400,65359,Comparative Toxicogenomics Database (CTD),Oxiglutatione,D019803,Glutathione Disulfide,https://ctdbase.org/detail.go?type=chem&acc=D019803,6622,SNCA,https://ctdbase.org/detail.go?type=gene&acc=6622,,,6622.0,SNCA,9606,Homo sapiens (human),SNCA protein results in decreased abundance of glutathione disulfide,,,PMID:27424009,https://www.ncbi.nlm.nih.gov/pubmed/27424009,27424009,,
28,1349401,65359,Comparative Toxicogenomics Database (CTD),Oxiglutatione,D019803,Glutathione Disulfide,https://ctdbase.org/detail.go?type=chem&acc=D019803,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606,Homo sapiens (human),SOD1 protein mutant form results in increased abundance of glutathione disulfide,,,PMID:11181815,https://www.ncbi.nlm.nih.gov/pubmed/11181815,11181815,,
29,1349527,65359,Comparative Toxicogenomics Database (CTD),Oxiglutatione,D019803,Glutathione Disulfide,https://ctdbase.org/detail.go?type=chem&acc=D019803,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606,Homo sapiens (human),Glutathione disulfide results in increased activity of ABCC1 protein,,,PMID:11306701,https://www.ncbi.nlm.nih.gov/pubmed/11306701,11306701,,
30,1349528,65359,Comparative Toxicogenomics Database (CTD),Oxiglutatione,D019803,Glutathione Disulfide,https://ctdbase.org/detail.go?type=chem&acc=D019803,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,10116,Rattus norvegicus (Norway rat),ABCC1 protein results in increased export of glutathione disulfide|[epinephrine co-treated with [verlukast results in decreased activity of ABCC1 protein]] results in increased abundance of glutathione disulfide,,,PMID:19053318,https://www.ncbi.nlm.nih.gov/pubmed/19053318,19053318,,
31,1348982,65399,Drug Gene Interaction database (DGIdb),Triciribine,,TRICIRIBINE,https://www.dgidb.org/drugs/ncit:C142998,,AKT3,https://www.dgidb.org/genes/hgnc:393,,,10000.0,AKT3,9606,Homo sapiens (human),,,,,,,,
32,1348983,65399,Drug Gene Interaction database (DGIdb),Triciribine,,TRICIRIBINE,https://www.dgidb.org/drugs/ncit:C142998,,NFE2L2,https://www.dgidb.org/genes/hgnc:7782,,,4780.0,NFE2L2,9606,Homo sapiens (human),,,,,,,,
33,1349129,65948,Drug Gene Interaction database (DGIdb),Azelnidipine,,AZELNIDIPINE,https://www.dgidb.org/drugs/ncit:C73023,,CACNA1C,https://www.dgidb.org/genes/hgnc:1390,,,775.0,CACNA1C,9606,Homo sapiens (human),Blocker,,,,,,,
34,1349130,65954,Drug Gene Interaction database (DGIdb),Intoplicine,,INTOPLICINE,https://www.dgidb.org/drugs/ncit:C1495,,TOP 1.00,https://www.dgidb.org/genes/hgnc:11986,,,7150.0,TOP1,9606,Homo sapiens (human),,,,,,,,
35,1349131,65981,Drug Gene Interaction database (DGIdb),Repaglinide,,REPAGLINIDE,https://www.dgidb.org/drugs/rxcui:73044,,KCNJ11,https://www.dgidb.org/genes/hgnc:6257,,,3767.0,KCNJ11,9606,Homo sapiens (human),,,,,,,,
36,1349132,65981,Drug Gene Interaction database (DGIdb),Repaglinide,,REPAGLINIDE,https://www.dgidb.org/drugs/rxcui:73044,,KCNJ1,https://www.dgidb.org/genes/hgnc:6255,,,3758.0,KCNJ1,9606,Homo sapiens (human),,,,,,,,
37,1349124,66259,Drug Gene Interaction database (DGIdb),Oxymetazoline Hydrochloride,,OXYMETAZOLINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:106101,,ADRA1A,https://www.dgidb.org/genes/hgnc:277,,,148.0,ADRA1A,9606,Homo sapiens (human),Agonist,,,,,,,
38,1349125,66259,Drug Gene Interaction database (DGIdb),Oxymetazoline Hydrochloride,,OXYMETAZOLINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:106101,,ADRA2A,https://www.dgidb.org/genes/hgnc:281,,,150.0,ADRA2A,9606,Homo sapiens (human),,,,,,,,
39,1349126,66259,Drug Gene Interaction database (DGIdb),Oxymetazoline Hydrochloride,,OXYMETAZOLINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:106101,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606,Homo sapiens (human),,,,,,,,
40,1349127,66259,Drug Gene Interaction database (DGIdb),Oxymetazoline Hydrochloride,,OXYMETAZOLINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:106101,,ADRA2A,https://www.dgidb.org/genes/hgnc:281,,,150.0,ADRA2A,9606,Homo sapiens (human),,,,,,,,
41,1349128,66259,Drug Gene Interaction database (DGIdb),Oxymetazoline Hydrochloride,,OXYMETAZOLINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:106101,,CYP2D6,https://www.dgidb.org/genes/hgnc:2625,,,1565.0,CYP2D6,9606,Homo sapiens (human),,,,,,,,
42,1349402,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,1174,AP1S1,https://ctdbase.org/detail.go?type=gene&acc=1174,,,1174.0,AP1S1,7955,Danio rerio (zebrafish),Perfluorohexanoic acid results in increased expression of AP1S1 mRNA,,,PMID:30669116,https://www.ncbi.nlm.nih.gov/pubmed/30669116,30669116,,
43,1349403,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,336,APOA2,https://ctdbase.org/detail.go?type=gene&acc=336,,,336.0,APOA2,9606,Homo sapiens (human),Perfluorohexanoic acid results in increased expression of APOA2 mRNA,,,PMID:23567314,https://www.ncbi.nlm.nih.gov/pubmed/23567314,23567314,,
44,1349404,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,337,APOA4,https://ctdbase.org/detail.go?type=gene&acc=337,,,337.0,APOA4,10116,Rattus norvegicus (Norway rat),Perfluorohexanoic acid results in increased expression of APOA4 mRNA,,,PMID:22071372,https://www.ncbi.nlm.nih.gov/pubmed/22071372,22071372,,
45,1349405,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,116519,APOA5,https://ctdbase.org/detail.go?type=gene&acc=116519,,,116519.0,APOA5,9606,Homo sapiens (human),Perfluorohexanoic acid results in increased expression of APOA5 mRNA,,,PMID:23567314,https://www.ncbi.nlm.nih.gov/pubmed/23567314,23567314,,
46,1349406,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),Perfluorohexanoic acid promotes the reaction [dihydrotestosterone results in increased activity of AR protein],,,PMID:29601859,https://www.ncbi.nlm.nih.gov/pubmed/29601859,29601859,,
47,1349407,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,7955,Danio rerio (zebrafish),Perfluorohexanoic acid results in increased expression of BDNF mRNA,,,PMID:30669116,https://www.ncbi.nlm.nih.gov/pubmed/30669116,30669116,,
48,1349529,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,140634,CYP1A,https://ctdbase.org/detail.go?type=gene&acc=140634,,,140634.0,cyp1a,7955,Danio rerio (zebrafish),"[perfluorooctane sulfonic acid co-treated with perfluorohexanoic acid] inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in increased expression of CYP1A mrna]",,,PMID:28283292,https://www.ncbi.nlm.nih.gov/pubmed/28283292,28283292,,
49,1349530,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9031,Gallus gallus (chicken),Perfluorohexanoic acid results in increased expression of CYP1A1 mRNA,,,PMID:19617454,https://www.ncbi.nlm.nih.gov/pubmed/19617454,19617454,,
50,1349531,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,664714,CYP1A5,https://ctdbase.org/detail.go?type=gene&acc=664714,,,664714.0,,9031,Gallus gallus (chicken),Perfluorohexanoic acid results in increased expression of CYP1A5 mRNA,,,PMID:19617454,https://www.ncbi.nlm.nih.gov/pubmed/19617454,19617454,,
51,1349532,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,1555,CYP2B6,https://ctdbase.org/detail.go?type=gene&acc=1555,,,1555.0,CYP2B6,9606,Homo sapiens (human),Perfluorohexanoic acid results in increased expression of CYP2B6 mRNA,,,PMID:23567314|PMID:35337807,https://www.ncbi.nlm.nih.gov/pubmed/23567314|https://www.ncbi.nlm.nih.gov/pubmed/35337807,23567314|35337807,,
52,1349533,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,50549,CYP4A1,https://ctdbase.org/detail.go?type=gene&acc=50549,,,50549.0,Cyp4a1,10116,Rattus norvegicus (Norway rat),Perfluorohexanoic acid results in increased expression of CYP4A1 mRNA,,,PMID:19407336,https://www.ncbi.nlm.nih.gov/pubmed/19407336,19407336,,
53,1349534,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,1579,CYP4A11,https://ctdbase.org/detail.go?type=gene&acc=1579,,,1579.0,CYP4A11,9606,Homo sapiens (human),Perfluorohexanoic acid results in increased expression of CYP4A11 mRNA,,,PMID:35337807,https://www.ncbi.nlm.nih.gov/pubmed/35337807,35337807,,
54,1349535,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,13119,CYP4A14,https://ctdbase.org/detail.go?type=gene&acc=13119,,,13119.0,Cyp4a14,10090,Mus musculus (house mouse),Perfluorohexanoic acid results in increased expression of CYP4A14 mRNA,,,PMID:23567314,https://www.ncbi.nlm.nih.gov/pubmed/23567314,23567314,,
55,1349665,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,2168,FABP1,https://ctdbase.org/detail.go?type=gene&acc=2168,,,2168.0,FABP1,10090,Mus musculus (house mouse),Perfluorohexanoic acid results in increased expression of FABP1 mRNA,,,PMID:23567314|PMID:36435305,https://www.ncbi.nlm.nih.gov/pubmed/23567314|https://www.ncbi.nlm.nih.gov/pubmed/36435305,23567314|36435305,,
56,1349666,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,2194,FASN,https://ctdbase.org/detail.go?type=gene&acc=2194,,,2194.0,FASN,9606,Homo sapiens (human),Perfluorohexanoic acid results in increased expression of FASN mRNA,,,PMID:35337807,https://www.ncbi.nlm.nih.gov/pubmed/35337807,35337807,,
57,1349667,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,2222,FDFT1,https://ctdbase.org/detail.go?type=gene&acc=2222,,,2222.0,FDFT1,10116,Rattus norvegicus (Norway rat),Perfluorohexanoic acid results in increased expression of FDFT1 mRNA,,,PMID:22071372,https://www.ncbi.nlm.nih.gov/pubmed/22071372,22071372,,
58,1349668,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,2312,FLG,https://ctdbase.org/detail.go?type=gene&acc=2312,,,2312.0,FLG,10090,Mus musculus (house mouse),Perfluorohexanoic acid results in increased expression of FLG mRNA,,,PMID:36435305,https://www.ncbi.nlm.nih.gov/pubmed/36435305,36435305,,
59,1349669,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,57678,GPAM,https://ctdbase.org/detail.go?type=gene&acc=57678,,,57678.0,GPAM,9606,Homo sapiens (human),Perfluorohexanoic acid results in increased expression of GPAM mRNA,,,PMID:35337807,https://www.ncbi.nlm.nih.gov/pubmed/35337807,35337807,,
60,1349670,67542,Comparative Toxicogenomics Database (CTD),Perfluorohexanoic acid,C479228,perfluorohexanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C479228,352926,GPX1A,https://ctdbase.org/detail.go?type=gene&acc=352926,,,352926.0,gpx1a,7955,Danio rerio (zebrafish),"[3,4,5,3',4'-pentachlorobiphenyl co-treated with perfluorohexanoic acid co-treated with perfluorooctane sulfonic acid] results in increased expression of GPX1A mrna|[3,4,5,3',4'-pentachlorobiphenyl co-treated with perfluorohexanoic acid] results in increased expression of GPX1A mRNA",,,PMID:28283292,https://www.ncbi.nlm.nih.gov/pubmed/28283292,28283292,,
61,1349274,67686,Drug Gene Interaction database (DGIdb),Sulbentine,,SULBENTINE,https://www.dgidb.org/drugs/ncit:C72964,,GMNN,https://www.dgidb.org/genes/hgnc:17493,,,51053.0,GMNN,9606,Homo sapiens (human),,,,,,,,
62,1349275,68094,Comparative Toxicogenomics Database (CTD),Harmol,C001326,harmol,https://ctdbase.org/detail.go?type=chem&acc=C001326,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10141,Cavia porcellus (domestic guinea pig),Harmol inhibits the reaction [tetrachlorodibenzodioxin results in increased activity of [AHR protein binds to ARNT protein]]|harmol inhibits the reaction [tetrachlorodibenzodioxin binds to AHR protein],,,PMID:22001777,https://www.ncbi.nlm.nih.gov/pubmed/22001777,22001777,,
63,1349671,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,150468,CKAP2L,https://ctdbase.org/detail.go?type=gene&acc=150468,,,150468.0,CKAP2L,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CKAP2L mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
64,1349672,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10970,CKAP4,https://ctdbase.org/detail.go?type=gene&acc=10970,,,10970.0,CKAP4,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of CKAP4 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CKAP4 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
65,1349673,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,9793,CKAP5,https://ctdbase.org/detail.go?type=gene&acc=9793,,,9793.0,CKAP5,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of CKAP5 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
66,1348830,89859,Toxin and Toxin Target Database (T3DB),Aluminum arsenide (AlAs),T3D1289,Aluminium arsenide,http://www.t3db.ca/toxins/T3D1289,BE0005087,Tubulin beta-8 chain-like protein LOC260334,http://www.t3db.ca/biodb/bio_entities/BE0005087,A6NNZ2,Tubulin beta 8B,,,9606,Homo sapiens (human),"Arsenic's carginogenicity is believed to be caused by the arsenical binding of tubulin, which results in aneuploidy, polyploidy and mitotic arrests. (A17)",,,PMID:18164070,https://www.ncbi.nlm.nih.gov/pubmed/18164070,18164070,,
67,1348831,91272,Drug Gene Interaction database (DGIdb),Deoxyspergualin,,DEOXYSPERGUALIN,https://www.dgidb.org/drugs/drugbank:DB12991,,DHPS,https://www.dgidb.org/genes/hgnc:2869,,,1725.0,DHPS,9606,Homo sapiens (human),,,,,,,,
68,1348832,91274,Drug Gene Interaction database (DGIdb),Tiagabine Hydrochloride,,TIAGABINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:236875,,ABAT,https://www.dgidb.org/genes/hgnc:23,,,18.0,ABAT,9606,Homo sapiens (human),,,,,,,,
69,1348833,91457,Comparative Toxicogenomics Database (CTD),beta-EUDESMOL,C051082,beta-eudesmol,https://ctdbase.org/detail.go?type=chem&acc=C051082,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,10090,Mus musculus (house mouse),Beta-eudesmol inhibits the reaction [OVAL protein results in increased cleavage of and results in increased activity of CASP1 protein],,,PMID:30148989,https://www.ncbi.nlm.nih.gov/pubmed/30148989,30148989,,
70,1348834,91457,Comparative Toxicogenomics Database (CTD),beta-EUDESMOL,C051082,beta-eudesmol,https://ctdbase.org/detail.go?type=chem&acc=C051082,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920.0,CXCL2,10090,Mus musculus (house mouse),Beta-eudesmol inhibits the reaction [OVAL protein results in increased expression of CXCL2 protein],,,PMID:30148989,https://www.ncbi.nlm.nih.gov/pubmed/30148989,30148989,,
